Figure 1 | Scientific Reports

Figure 1

From: Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib

Figure 1

(A) Response of cells to sorafenib detected by MTS assay. The average of three independent experiments and SD are shown. (B) Representative Western blot analysis reporting the expression and the phosphorylation of different proteins belonging to the MAPK and PI3K pathways in the KRAS-expressing clones treated with sorafenib 1 uM, at the indicated time points.

Back to article page